Viking Therapeutics VKTX
NASDAQ VKTX
$24.40 -1.43 (-5.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Non Operating Investment Income (2024 - 2026)

Updated

Viking Therapeutics (VKTX) reported Non Operating Investment Income of $30,000 for Q2 2026, up 650.0% from $4,000 a year earlier.

Analysis

Viking Therapeutics (VKTX) Non Operating Investment Income (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Viking Therapeutics' Non Operating Investment Income came in at $144,000, up 24.1% year-over-year; for FY2025, it came in at $55,000, down 50.9% from FY2024.

  • By year, Non Operating Investment Income came in at $112,000 in FY2024 and -$42,000 in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Non Operating Investment Income since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Viking Therapeutics 2.85 Bn 321.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30,000.00
Jun 30, 2025 4,000.00
Dec 31, 2024 1,000.00
Sep 30, 2024 109,000.00
Jun 30, 2024 2,000.00
API Access

Viking Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=VKTX&period=max&api_key=YOUR_API_KEY